Email this page: News Release
Vertex Pharmaceuticals Announces Agreements to Exchange $103.3 Million of its 2013 Convertible Senior Subordinated Notes into Common Stock
To (email address):
Separate multiple addresses with commas. Maximum 200 characters.
Your name:
Your email address:
Copy yourself
These email addresses will be used to email the page on your behalf and will not be used by Vertex Pharmaceuticals Incorporated for any marketing purposes.
Add a comment:
Send:
Full page
Link to page
Type in number:
This helps Vertex Pharmaceuticals Incorporated prevent automated submissions.
